Van Naarden Jacob
Chief Business Officer at Loxo Oncology, Inc.
- Sold, on record
- $11.8M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Dec 11, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Loxo Oncology, Inc.Chief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Loxo Oncology, Inc.UnusualMay 15 2018
Sold 3,082 shares at $137.42 ($424k)
Van Naarden Jacob, Chief Business Officer
Sold 100% of holdings ($424k position)0 shares left1x usual sizeFiling
- 2 Form 4 sale Loxo Oncology, Inc.Plan not statedJun 20 +36 days
Sold 3,082 shares at $178.14 ($549k)
Van Naarden Jacob, Chief Business Officer
Sold 20.4% of holdings ($2.7M position)12,000 shares left1x usual sizeFiling
- 3 Form 4 sale Loxo Oncology, Inc.Plan not statedJul 10 +20 days
Sold 3,082 shares at $183.50 ($566k)
Van Naarden Jacob, Chief Business Officer
Sold 18.4% of holdings ($3.1M position)13,700 shares left1x usual sizeFiling
- 4 Form 4 sale Loxo Oncology, Inc.UnusualAug 14 +35 days
Sold 10,000 shares at $159.35 ($1.6M)
Van Naarden Jacob, Chief Business Officer
Sold 42.2% of holdings ($3.8M position)13,700 shares left3.2x usual sizeFiling
- 5 Form 4 sale Loxo Oncology, Inc.UnusualSep 13 +30 days
Sold 10,000 shares at $166.32 ($1.7M)
Van Naarden Jacob, Chief Business Officer
Sold 42.2% of holdings ($3.9M position)13,700 shares left3.2x usual sizeFiling
- 6 Form 4 sale Loxo Oncology, Inc.UnusualOct 4 +21 days
Sold 10,000 shares at $165.13 ($1.7M)
Van Naarden Jacob, Chief Business Officer
Sold 42.2% of holdings ($3.9M position)13,700 shares left3.2x usual sizeFiling
- 7 Form 4 sale Loxo Oncology, Inc.UnusualNov 27 +54 days
Sold 10,000 shares at $147.97 ($1.5M)
Van Naarden Jacob, Chief Business Officer
Sold 42.2% of holdings ($3.5M position)13,700 shares left3.2x usual sizeFiling
- 8 Form 4 sale Loxo Oncology, Inc.UnusualDec 11 +14 days
Sold 9,000 shares at $135.50 ($1.2M)
Van Naarden Jacob, Chief Business Officer
Sold 39.6% of holdings ($3.1M position)13,700 shares left2.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 9,000 | $1.2M | 39.6% | Unusual | SEC |
| Nov 27, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 10,000 | $1.5M | 42.2% | Unusual | SEC |
| Oct 4, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 10,000 | $1.7M | 42.2% | Unusual | SEC |
| Sep 13, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 10,000 | $1.7M | 42.2% | Unusual | SEC |
| Aug 14, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 10,000 | $1.6M | 42.2% | Unusual | SEC |
| Jul 10, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $566k | 18.4% | Plan not stated | SEC |
| Jun 20, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $549k | 20.4% | Plan not stated | SEC |
| May 15, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $424k | 100.0% | Unusual | SEC |
| Apr 25, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $404k | 100.0% | Unusual | SEC |
| Mar 14, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $405k | 100.0% | Unusual | SEC |
| Feb 13, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $297k | 100.0% | Unusual | SEC |
| Jan 17, 2018 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $272k | 100.0% | Unusual | SEC |
| Dec 15, 2017 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $250k | 100.0% | Unusual | SEC |
| Nov 28, 2017 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $230k | 100.0% | Unusual | SEC |
| Oct 31, 2017 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $268k | 100.0% | Unusual | SEC |
| Sep 19, 2017 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $274k | 100.0% | Unusual | SEC |
| Aug 15, 2017 | Loxo Oncology, Inc. | Chief Business Officer | Form 4 sale | 3,082 | $227k | 100.0% | Unusual | SEC |